Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit MelanomaRyan S. Turley, Douglas S. Tyler, Andrew N. Fontanella et al.|Clinical Cancer Research|2012Cited by 57
Examining the role of wide excision margins in pediatric melanoma: A National Cancer Database analysisNorma E. Farrow, Elisabeth T. Tracy, Jina Kim et al.|Pediatric Blood & Cancer|2022Cited by 5
National Trends in Management of the Nodal Basin for Pediatric Patients With Occult Stage III Melanoma in the United StatesCatherine B Beckhorn, Elisabeth T. Tracy, Kristen E. Rhodin et al.|Pediatric Blood & Cancer|2025Cited by 1
Supplementary Figure Legend from Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit MelanomaRyan S. Turley, Douglas S. Tyler, Andrew N. Fontanella et al.|Unknown|2023Cited by 0
Data from Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit MelanomaRyan S. Turley, Douglas S. Tyler, Andrew N. Fontanella et al.|Unknown|2023Cited by 0